PubmedID,Title,Publication Date,Non-academic Authors,Company Affiliations,Corresponding Author Email
40054035,Quantitative prediction of drug disposition for uridine diphosphate-glucuronosyltransferase substrates using humanized mice.,2025,"Taiji Miyake, Yuito Fujita, Keiichi Morita, Tatsuhiko Tachibana, Kimio Terao","Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan. Electronic address: miyake.taiji61@chugai-pharm.co.jp., Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan., Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan., Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan. Electronic address: tachibanatth@chugai-pharm.co.jp., Pharmaceutical Science Department, Translational Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama-shi, Japan.",10.1016/j.dmd.2025.100050
40053846,"Multitask Deep Learning Models of Combined Industrial Absorption, Distribution, Metabolism, and Excretion Datasets to Improve Generalization.",2025,"Joseph A Napoli, Michael Reutlinger, Patricia Brandl, Wenyi Wang, Jérôme Hert, Prashant Desai","Drug Metabolism & Pharmacokinetics (DMPK), Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., F. Hoffmann-La Roche Ltd., Pharma Research & Early Development (pRED), Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland., F. Hoffmann-La Roche Ltd., Pharma Research & Early Development (pRED), Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland., Drug Metabolism & Pharmacokinetics (DMPK), Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States., F. Hoffmann-La Roche Ltd., Pharma Research & Early Development (pRED), Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland., Drug Metabolism & Pharmacokinetics (DMPK), Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.",10.1021/acs.molpharmaceut.4c01086
40053676,Cheminformatic Analysis of Core-Atom Transformations in Pharmaceutically Relevant Heteroaromatics.,2025,"Reilly M Eason, Charles S Yeung","Modeling & Informatics, Merck & Co., Inc., Boston, Massachusetts 02115, United States., Discovery Chemistry, Merck & Co., Inc., Boston, Massachusetts 02115, United States.",10.1021/acs.jmedchem.4c02839
40053572,Hafnium-Doped Prussian Blue Nanoparticles with Homologous Tumor Targeting and Magnetic Resonance Imaging Ability for Enhanced Tumor Radiotherapy via Photothermal Therapy and Hypoxia Relief.,2025,Renpin Liu,"Fujian Key Laboratory of Pollution Control & Resource Reuse, Fuzhou 350122, China.",10.1021/acs.bioconjchem.5c00064
40053484,Discovery of New Azaindole Metallo-Deubiquitinase CSN5 Inhibitors.,2025,None,None,10.1021/acs.jmedchem.5c00184
